Takeda Won't Commit To Cover Eli Lilly For $9B Verdict
Takeda Pharmaceutical Co. Ltd. isn't conceding that it needs to pay Eli Lilly & Co.'s piece of a $9 billion verdict against the two companies for allegedly hiding the cancer risks...To view the full article, register now.
Already a subscriber? Click here to view full article